These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 11499029)

  • 1. [Studies on the synthesis and activities of RGD related peptides].
    Zhao M; Peng SQ; Dilinuer S; Wang YY; Zhou QL; Zhao WZ
    Yao Xue Xue Bao; 1997 Apr; 32(4):271-7. PubMed ID: 11499029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and antithrombotic activity of carbolinecarboxyl RGD sequence.
    Lin N; Zhao M; Wang C; Peng S
    Bioorg Med Chem Lett; 2002 Feb; 12(4):585-7. PubMed ID: 11844677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The application of tetrahydroisoquinoline-3-carbonyl-TARGD(F)F as an anti-thrombotic agent having dual mechanisms of action.
    Yang G; Zhu H; Zhao M; Wu J; Wang Y; Wang Y; Zheng M; Chen M; Liu J; Peng S
    Mol Biosyst; 2012 Oct; 8(10):2672-9. PubMed ID: 22801714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of RGD containing peptides and their vasodilation effect.
    Ming Z; Chao W; Jian Y; Shiqi P
    Prep Biochem Biotechnol; 2000 Aug; 30(3):247-56. PubMed ID: 10919564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of RGD containing peptides and their bioactivities.
    Zhao M; Wang C; Jiang X; Pen S
    Prep Biochem Biotechnol; 2002 Nov; 32(4):363-80. PubMed ID: 12455829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiplatelet and antithrombotic effects of platelet glycoprotein IIb/IIIa (GPIIb/IIIa) inhibition by arginine-glycine-aspartic acid-serine (RGDS) and arginine-glycine-aspartic acid (RGD) (O-me)Y (SC-46749).
    Nicholson NS; Panzer-Knodle SG; Salyers AK; Taite BB; King LW; Miyano M; Gorczynski RJ; Williams MH; Zupec ME; Tjoeng FS
    J Pharmacol Exp Ther; 1991 Mar; 256(3):876-82. PubMed ID: 2005585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of low molecular weight GP IIb/IIIa antagonists that bind preferentially to activated platelets.
    Bednar RA; Gaul SL; Hamill TG; Egbertson MS; Shafer JA; Hartman GD; Gould RJ; Bednar B
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1317-26. PubMed ID: 9618439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and cardioprotective effect of a new class of dual-acting agents: phenolic tetrahydro-beta-carboline RGD peptidomimetic conjugates.
    Bi W; Cai J; Liu S; Baudy-Floc'h M; Bi L
    Bioorg Med Chem; 2007 Nov; 15(22):6909-19. PubMed ID: 17827017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel fibrinogen receptor antagonists. RGDF mimetics, derivatives of 4-(isoindoline-5-yl)amino-4-oxobutyric acid.
    Krysko AA; Chugunov BM; Malovichko OL; Andronati SA; Kabanova TA; Karaseva TL; Kiriyak AV
    Bioorg Med Chem Lett; 2004 Nov; 14(22):5533-5. PubMed ID: 15482918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and bioactivities of nitronyl nitroxide and RGD containing pseudopeptides.
    Liu J; Zhao M; Wang C; Peng S
    Bioorg Med Chem Lett; 2003 Nov; 13(22):4065-9. PubMed ID: 14592509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of cyclic oligopeptides containing an Arg-Gly-Asp (RGD) sequence.
    Sofuku S; Hoshida A; Shimada T; Takada Y; Takakuwa T
    Chem Pharm Bull (Tokyo); 1999 Dec; 47(12):1799-801. PubMed ID: 10748723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of novel biologically active thrombin receptor non-peptide mimetics based on the pharmacophoric cluster Phe/Arg/NH2 of the Ser42-Phe-Leu-Leu-Arg46 motif sequence: platelet aggregation and relaxant activities.
    Alexopoulos K; Fatseas P; Melissari E; Vlahakos D; Roumelioti P; Mavromoustakos T; Mihailescu S; Paredes-Carbajal MC; Mascher D; Matsoukas J
    J Med Chem; 2004 Jun; 47(13):3338-52. PubMed ID: 15189031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-Substituted (S)-2-(3,3-dimethyl-1-oxo-10,10a-dihydroimidazo[1,5-b]isoquinolin-2(1H,3H,5H)-yl)acetic acids: Conformational prediction, synthesis, anti-thrombotic and vasodilative evaluation.
    Wang H; Peng L; Zhao M; Liu J; Zhang X; Wang Y; Wu J; Li L; Peng S
    Bioorg Med Chem; 2011 Jan; 19(2):871-82. PubMed ID: 21193315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A new thrombocyte aggregation-inhibiting and fibrinolysis-promoting synthetic molecule: RGDF (Arg-Gly-Asp-Phe) coupled with the carboxyterminal antiplasmin peptide].
    Udrardy M; Schwartzott D; Jackson K; McKee PA
    Orv Hetil; 1995 Jan; 136(3):129-33. PubMed ID: 7870410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antiaggregatory activity of RGD-peptidomimetics based on 4-oxo-4-(piperazine-1-yl)butyric acid as Arg-mimetic.
    Andronati SA; Krysko AA; Kabanov VM; Kabanova TA; Karaseva TL; Chugunov BM; Meshkova SB; Topilova ZM
    Acta Pol Pharm; 2003; 60(5):375-81. PubMed ID: 15005421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationships of RGD mimetics as fibrinogen-receptor antagonists.
    Miyashita M; Akamatsu M; Ueno H; Nakagawa Y; Nishimura K; Hayashi Y; Sato Y; Ueno T
    Biosci Biotechnol Biochem; 1999 Oct; 63(10):1684-90. PubMed ID: 10586496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of integrin-mediated platelet aggregation, fibrinogen-binding, and interactions with extracellular matrix by nonpeptidic mimetics of Arg-Gly-Asp.
    Varon D; Lider O; Dardik R; Shenkman B; Alon R; Hershkoviz R; Kapustina G; Savion N; Martinowitz U; Greenspoon N
    Thromb Haemost; 1993 Dec; 70(6):1030-6. PubMed ID: 8165596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, antiplatelet and vasorelaxing activities of xanthone derivatives.
    Lin KW; Fang SC; Hung CF; Shieh BJ; Yang SC; Teng CM; Lin CN
    Arch Pharm (Weinheim); 2009 Jan; 342(1):19-26. PubMed ID: 19035386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional relevance of the expression of ligand-induced binding sites in the response to platelet GP IIb/IIIa antagonists in vivo.
    Murphy NP; Pratico D; Fitzgerald DJ
    J Pharmacol Exp Ther; 1998 Aug; 286(2):945-51. PubMed ID: 9694954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and thrombolytic activity of pseudopeptides related to fibrinogen fragment.
    Wu Y; Zhao M; Wang C; Peng S
    Bioorg Med Chem Lett; 2002 Sep; 12(17):2331-3. PubMed ID: 12161127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.